↓ Skip to main content

Evaluation of Montelukast for the Prevention of Infusion-related Reactions With Daratumumab

Overview of attention for article published in Clinical Lymphoma, Myeloma & Leukemia, October 2020
Altmetric Badge

Mentioned by

twitter
2 tweeters

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evaluation of Montelukast for the Prevention of Infusion-related Reactions With Daratumumab
Published in
Clinical Lymphoma, Myeloma & Leukemia, October 2020
DOI 10.1016/j.clml.2020.05.024
Pubmed ID
Authors

Donald C. Moore, Justin R. Arnall, Daniel L. Thompson, Allison L. Martin, Jordan Robinson, Ami Ndiaye, Barry Paul, Shebli Atrash, Manisha Bhutani, Peter M. Voorhees, Saad Z. Usmani

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 1 25%
Student > Bachelor 1 25%
Other 1 25%
Student > Doctoral Student 1 25%
Readers by discipline Count As %
Medicine and Dentistry 2 50%
Neuroscience 1 25%
Pharmacology, Toxicology and Pharmaceutical Science 1 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 July 2020.
All research outputs
#13,180,709
of 16,587,222 outputs
Outputs from Clinical Lymphoma, Myeloma & Leukemia
#736
of 1,121 outputs
Outputs of similar age
#214,260
of 292,486 outputs
Outputs of similar age from Clinical Lymphoma, Myeloma & Leukemia
#43
of 74 outputs
Altmetric has tracked 16,587,222 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,121 research outputs from this source. They receive a mean Attention Score of 3.6. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 292,486 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.